You may experience appetite suppression within 1-2 weeks of starting the treatment
Improves metabolic health and fatty liver disease (NAFLD)
Tirzepatide: A Multi-Benefit Solution for Weight Loss and Metabolic Health Contact us Frequently Asked Questions (FAQs) Tirzepatide is a dual-action GIP and GLP-1 receptor agonist that suppresses appetite, enhances insulin sensitivity, and promotes sustainable weight loss
Our weight loss program in Midland, Texas uses GLP-1 medications including Ozempic, Mounjaro, Wegovy, Zepbound, and more to help patients lose weight and reach their goals under the guidance of a licensed provider
Inform healthcare providers about GHK-Cu use before any procedures Monitor for unusual skin reactions or systemic effects Consider periodic copper and zinc level testing for extended protocols Start with lower doses and increase gradually to assess tolerance Use only pharmaceutical-grade peptides from reputable sources For extended use protocols, periodic laboratory monitoring adds an additional layer of safety